"10.1371_journal.pone.0106131","plos one","2014-08-29T00:00:00Z","Zolt√°n Dezs≈ë; Judith Oestreicher; Amy Weaver; Stephanie Santiago; Sergei Agoulnik; Jesse Chow; Yoshiya Oda; Yasuhiro Funahashi","Biomarkers and Personalized Medicine Core Function Unit, Eisai Product Creation Systems, Eisai Inc., Andover, Massachusetts, United States of America","Conceived and designed the experiments: ZD JO SA JC YO YF. Performed the experiments: JO AW SS SA. Analyzed the data: ZD JO YF. Contributed reagents/materials/analysis tools: JO AW SS SA JC YO. Wrote the paper: ZD.","The authors have read the journal‚Äôs policy and have the following conflicts. All authors were employed by Eisai Inc., the funder of this study. Eribulin is an Eisai product. There are no further patents, products in development or marketed products to declare. This does not alter their adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2014","08","Zolt√°n Dezs≈ë","Z√D≈",8,TRUE,6,4,3,1,TRUE,TRUE,FALSE,0,NA,FALSE
